50 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
TMO Thermo Fisher Scientific Inc $238.46 $96.05B N/A
Article Searches
Stryker (SYK) Q3 Earnings Meet Estimates, Revenues Beat http://www.zacks.com/stock/news/592590/stryker-syk-q3-earnings-meet-estimates-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-592590 Oct 30, 2019 - Stryker's (SYK) Q3 earnings gain from higher revenues, solid segmental performance and strong organic growth across businesses benefit.
Masimo (MASI) Earnings Beat Estimates in Q3, View Raised http://www.zacks.com/stock/news/594844/masimo-masi-earnings-beat-estimates-in-q3-view-raised?cid=CS-ZC-FT-analyst_blog|earnings_article-594844 Oct 31, 2019 - Masimo (MASI) raises its 2019 product revenue guidance.
Amedisys (AMED) Q3 Earnings Beat Estimates, Revenues Meet http://www.zacks.com/stock/news/596670/amedisys-amed-q3-earnings-beat-estimates-revenues-meet?cid=CS-ZC-FT-analyst_blog|earnings_article-596670 Oct 31, 2019 - Amedisys (AMED) continues to witness solid year-over-year growth in Medicare and non-Medicare revenues within Home Health.
Impressive Near-Term Outlook for Medical Instruments Industry http://www.zacks.com/commentary/595185/impressive-near-term-outlook-for-medical-instruments-industry?cid=CS-ZC--industry_outlook-595185 Oct 31, 2019 - Impressive Near-Term Outlook for Medical Instruments Industry
NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q3 http://www.zacks.com/stock/news/597826/nuvasive-nuva-earnings-and-revenues-beat-estimates-in-q3?cid=CS-ZC-FT-analyst_blog|earnings_article-597826 Nov 01, 2019 - We are encouraged to note that NuVasive (NUVA) witnessed solid revenue growth across its U.S. Spinal Hardware business in Q3.
AMN Healthcare (AMN) Q3 Earnings and Revenues Top Estimates http://www.zacks.com/stock/news/597964/amn-healthcare-amn-q3-earnings-and-revenues-top-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-597964 Nov 01, 2019 - Nurse and Allied Solutions segment drives AMN Healthcare's (AMN) third-quarter results.
Teleflex (TFX) Earnings and Revenues Beat Estimates in Q3 http://www.zacks.com/stock/news/597897/teleflex-tfx-earnings-and-revenues-beat-estimates-in-q3?cid=CS-ZC-FT-analyst_blog|earnings_article-597897 Nov 01, 2019 - We are encouraged by Teleflex's (TFX) robust improvement in Q3 revenues on balanced growth across majority of segments and all geographies.
Syneos Health (SYNH) Tops Q3 Earnings Estimates, Ups EPS View http://www.zacks.com/stock/news/598401/syneos-health-synh-tops-q3-earnings-estimates-ups-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-598401 Nov 01, 2019 - Syneos Health (SYNH) exhibits robust topline performance in the third quarter, backed by strong segmental growth.
Intersect ENT (XENT) Reports Q3 Loss, Revenues Meet Estimates http://www.zacks.com/stock/news/602494/intersect-ent-xent-reports-q3-loss-revenues-meet-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-602494 Nov 04, 2019 - Intersect ENT (XENT) exhibits a dismal performance in the third quarter of 2019.
Allscripts (MDRX) Q3 Earnings Beat Estimates, Improve Y/Y http://www.zacks.com/stock/news/604633/allscripts-mdrx-q3-earnings-beat-estimates-improve-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-604633 Nov 05, 2019 - Allscripts (MDRX) third-quarter results gain from growth in bookings and solid segmental performance. Contraction in both gross and operating margins remains a woe.

Pages: 12345

Page 1>